Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

Journal of the National Cancer Institute

Volumn 98, Issue 1, 2006, Pages 51-60

  Smedby, Karin Ekström ^a   Hjalgrim, Henrik ^b   Askling, Johan ^c   Chang, Ellen T ^a   Gregersen, Henrik ^d   Porwit MacDonald, Anna ^a   Sundström, Christer ^e   Åkerman, Måns ^f   Melbye, Mads ^b   Glimelius, Bengt ^c,e   Adami, Hans Olov ^a,g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CELIAC DISEASE; CHRONIC INFLAMMATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; ENTERITIS; EXPOSURE; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SARCOIDOSIS; SJOEGREN SYNDROME; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LYMPHOMA;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; AUTOIMMUNITY; CASE-CONTROL STUDIES; CELIAC DISEASE; CELL DIFFERENTIATION; CHRONIC DISEASE; DENMARK; FEMALE; HUMANS; INFLAMMATION; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; SWEDEN; TIME FACTORS;

EID: 30344479938     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj004     Document Type: Article

References (59)

1. Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 2003;4:161-8.
2. Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy - is there an association? Scand J Rheumatol 2001;30:185-8.
3. Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003;48:963-70.
4. Bernatsky S, Clarke A, Ramsey-Goldman R. Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep 2002;4:351-8.
5. Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002;123: 1428-35.
6. Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002;287: 1413-9.
7. Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002;87:105-11.
8. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Sellers TA, Zheng W, et al. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 1997;89:314-8.
9. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A. Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 1997;241:471-5.
10. Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: Results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003;139: 1425-9.
11. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999;160: 1668-72.
12. Arseneau KO, Stukenborg GJ, Connors AF Jr, Cominelli F. The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis 2001;7:106-12.
13. Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extra-colonic malignancy in ulcerative colitis. Cancer 1986;58:1569-74.
14. Pearson JE, Silman AJ. Risk of cancer in patients with scleroderma. Ann Rheum Dis 2003;62:697-9.
15. Knight A, Askling J, Ekbom A. Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer 2002;100: 82-5.
16. Baecklund E, Sundstrom C, Ekbom A, Catrina AI, Biberfeld P, Feltelius N, et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003;48: 1543-50.
17. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 2002;99:3909-15.
18. Zulman J, Jaffe R, Talal N. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978;299:1215-20.
19. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-72.
20. Mariette X. Lymphomas in patients with Sjögren's syndrome: Review of the literature and physiopathologic hypothesis. Leuk Lymphoma 1999; 33:93-9.
21. Egan LJ, Walsh SV, Stevens FM, Connolly CE, Egan EL, McCarthy CF. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol 1995;21:123-9.
22. Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000;356:203-8.
23. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1072-82.
24. Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 1999;26:1676-80.
25. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18 572 patients. Arthritis Rheum 2004;50:1740-51.
26. Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998;317:180-1.
27. Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005;97:199-209.
28. Jaffe ES HN, Stein H, Vardiman JW, editor. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. Lyon (France): IARC Press; 2001.
29. Swedish Hospital Discharge Register 1987-1996, quality and contents. Stockholm (Sweden): Swedish National Board of Health and Welfare: Centre for Epidemiology; 1998.
30. Activity in the Hospital Care System 1979. Copenhagen (Denmark): Danish National Board of Health; 1981.
31. Chang ET, Smedby KE, Hjalgrim H, Schollkopf C, Porwit-Macdonald A, Sundstrom C, et al. Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2005;162:965-74.
32. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-14.
33. Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000;88:497-502.
34. Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: Clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001;60:467-72.
35. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease - effect of a gluten free diet. Gut 1989;30:333-8.
36. Hoshida Y, Tomita Y, Zhiming D, Yamauchi A, Nakatsuka S, Kurasono Y, et al. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 2004;108:443-9.
37. Palacios E, Larusso G, Rojas R, Ramirez G. Lymphoma of the parotid gland in Sjögren's syndrome. Ear Nose Throat J 2004;83:156.
38. Tonami H, Matoba M, Kuginuki Y, Yokota H, Higashi K, Yamamoto I, et al. Clinical and imaging findings of lymphoma in patients with Sjogren syndrome. J Comput Assist Tomogr 2003;27:517-24.
39. Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: Evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005;54:54-9.
40. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89: 1360-5.
41. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W. Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden. J Natl Cancer Inst 2003;95:1797-800.
42. Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 2001;117:1531-7.
43. Zackheim HS, McCalmont TH. Mycosis fungoides: The great imitator. J Am Acad Dermatol 2002;47:914-8.
44. Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001;121:1080-7.
45. Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005;54:617-22.
46. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356-61.
47. Yamamoto K. Pathogenesis of Sjögren's syndrome. Autoimmun Rev 2003;2:13-8.
48. Freitag T, Schulze-Koops H, Niedobitek G, Melino G, Schuppan D. The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmun Rev 2004;3:13-20.
49. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-15.
50. Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L. Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 2004;16: 254-61.
51. Eguchi K. Apoptosis in autoimmune diseases. Intern Med 2001;40: 275-84.
52. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: A community-based study of prevalence and impact. Br J Rheumatol 1998;37:1069-76.
53. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685-91.
54. Weile I, Grodzinsky E, Skogh T, Jordal R, Cavell B, Krasilnikoff PA. High prevalence rates of adult silent coeliac disease, as seen in Sweden, must be expected in Denmark. APMIS 2001;109:745-50.
55. Brandrup F, Green A. The prevalence of psoriasis in Denmark. Acta Derm Venereol 1981;61:344-6.
56. Fonager K, Sorensen HT, Olsen J. Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992. Int J Epidemiol 1997;26:1003-8.
57. Berger B, Stenstrom G, Chang YF, Sundkvist G. The prevalence of diabetes in a Swedish population of 280 411 inhabitants. A report from the Skaraborg Diabetes Registry. Diabetes Care 1998;21:546-8.
58. Isacson J, Allander E, Brostrom LA. A seventeen-year follow-up of a population survey of rheumatoid arthritis. Scand J Rheumatol 1987;16:145-52.
59. Simonsson M, Bergman S, Jacobsson LT, Petersson IF, Svensson B. The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol 1999;28:340-3.